Skip to content
L

Lovet Benyella Fokunang

Publications (4)

Preclinical Evaluation of the Anti-inflammatory Properties of Plants Extracts of Ficus exasperata (Moraceae) on Wistar Rat Models

Bate Antuan Asue, Edith Lem Abongwa, Vanessa Tchadji Mayoudom, Bayaga Herve Narcisse, Ndikum Valentine, Lovet Benyella Fokunang, Njinkio Nono Borgia, Estella Tembe-Fokunang, Bathelemy Ngameni, Sameh Abouzid & Charles Ntungwen Fokunang · Journal of Advances in Medical and Pharmaceutical Sciences · 2025

Introduction: In view of the rising global death rate associated with inflammatory diseases, a cost friendly, more effective and, safer drug with lesser side effects is needed.  Inflammation is a part of the complex biological response of vascular tissue to harmful stimuli, such...

Open access Research Article 10.9734/jamps/2025/v27i1746

An Overview of Pharmacovigilance and Adverse Drug Reaction Monitoring of Drugs and Vaccines during the COVID-19 Pandemic

Estella Achick Tembe-Fokunang, Banin Andrew Nyuki, Joseph Fokam, Dobgima John Fonmboh, Kristen Nubia Kaba, Lovet Benyella Fokunang, François-Xavier Mbopi-Keou, Abena, Ondoua Obama Marie Therese, Ralf Duerr & Charles Ntungwen Fokunang · Journal of Advances in Medical and Pharmaceutical Sciences · 2022

Once a drug is approved in phase III of clinical trials, pharmacovigilance (PV) becomes very important for the surveillance of drug, vaccine or medical devices. PV constitutes part of the phase IV approval, which involves a study for collecting, detecting, and monitoring adverse...

Open access Research Article 10.9734/jamps/2022/v24i630308

Pharmacovigilance in Cameroon: Past, Present and Future Developments in Unlocking the Drug Development Process

Estella Achick Tembe Fokunang, Bruna Njeba, Marie Jose Essi, Rose Ngono Abondo, Banin Andrew Nyuki, Lovet Benyella Fokunang, Nubia Kaba, Marie-Thérèse Abena Ondoua, Ralf Duerr & Charles Ntungwen Fokunang · Journal of Advances in Medical and Pharmaceutical Sciences · 2020

The drug discovery and development processes are designed to guarantee that drugs are efficacious, nontoxic and of high standards of quality for human consumption. However, patient’s population with access to drugs at approval is only a fraction of the final target population. Th...

Open access Research Article 10.9734/jamps/2020/v22i930192

Artificial Intelligence in Medical Research: Ethical and Regulatory Challenges in Developing Economies

Charles Ntungwen Fokunang, Marceline Djuidje Ngounoue, Joseph Fokam, Estella Achick Tembe-Fokunang, Basile Ngono, Innocente Mantsana, Mfochive Njindam Illiasou, Christie Tiwoda, Francis Ndongo Ateba, Tchinda Tiabou, Lowe Gnintedem Patrick Juvet, Pasteur Sap Jacques Duclaire, Mgr Etoundi Jean, Mpah Wanga Julien Eymard, Ngu Paul Nembo, Jerome Ateudjio, Charles Kouanfack, Eboumbou Moukoko Caroline Else, Leopold Lehman, Binan Fidele Ange, Lovet Benyella Fokunang, Atanga Benjamin, Zoung-Khanyi Bisseck Anne Cécile, Marie Claire Assoumou Okomo, Dickson Shey Nsagha, Mbacham Fon Wilfred, Marie Therese Obama Abena Ondoua, Zintchem Roger & Vincent Pryde Kehdingha Titanji · Journal of Advances in Medical and Pharmaceutical Sciences · 2025

Introduction: Clinical research is a key area in which the use of AI in healthcare data seen a significant increase, even though met with great ethical, legal and regulatory challenges. Artificial Intelligence (AI) concerns the ability of algorithms encoded in technology to learn...

Open access Research Article 10.9734/jamps/2025/v27i6788